Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_assertion type Assertion NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_head.
- NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_assertion description "[The slow acetylation (SA) phenotype for N-acetyltransferase 2 (NAT2) has been associated with toxicity from the anti-tuberculosis drug, isoniazid and in increased risk of select cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_provenance.
- NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_assertion evidence source_evidence_literature NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_provenance.
- NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_assertion SIO_000772 16799928 NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_provenance.
- NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_assertion wasDerivedFrom befree-20140225 NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_provenance.
- NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_assertion wasGeneratedBy ECO_0000203 NP366666.RAjJAk05K9wdyo80KcXWzZaKz4IJTKIK1On-CiNXC-Vac130_provenance.